LLY

776.45

-2.39%↓

JNJ

152.33

+0.12%↑

ABBV

182.26

-2.5%↓

NVO

68.53

+1.17%↑

UNH

308.74

+2.11%↑

LLY

776.45

-2.39%↓

JNJ

152.33

+0.12%↑

ABBV

182.26

-2.5%↓

NVO

68.53

+1.17%↑

UNH

308.74

+2.11%↑

LLY

776.45

-2.39%↓

JNJ

152.33

+0.12%↑

ABBV

182.26

-2.5%↓

NVO

68.53

+1.17%↑

UNH

308.74

+2.11%↑

LLY

776.45

-2.39%↓

JNJ

152.33

+0.12%↑

ABBV

182.26

-2.5%↓

NVO

68.53

+1.17%↑

UNH

308.74

+2.11%↑

LLY

776.45

-2.39%↓

JNJ

152.33

+0.12%↑

ABBV

182.26

-2.5%↓

NVO

68.53

+1.17%↑

UNH

308.74

+2.11%↑

Search

WaVe Life Sciences Ltd

Closed

6.63 -5.82

Overview

Share price change

24h

Current

Min

6.59

Max

7

Key metrics

By Trading Economics

Income

-76M

-47M

Sales

-75M

9.2M

EPS

-0.29

Profit margin

-510.932

Employees

287

EBITDA

-73M

-48M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+145.38% upside

Dividends

By Dow Jones

Next Earnings

7 sie 2025

Market Stats

By TradingEconomics

Market Cap

-36M

1B

Previous open

12.45

Previous close

6.63

Technical Score

By Trading Central

Confidence

Very Strong Bearish Evidence

WaVe Life Sciences Ltd Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

11 paź 2024, 15:56 UTC

Acquisitions, Mergers, Takeovers

GSK Bought More Shares of Biotech Wave Life Sciences -- Barrons.com

Peer Comparison

Price change

WaVe Life Sciences Ltd Forecast

Price Target

By TipRanks

145.38% upside

12 Months Forecast

Average 17.25 USD  145.38%

High 24 USD

Low 9 USD

Based on 9 Wall Street analysts offering 12 month price targets forWaVe Life Sciences Ltd - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

9 ratings

8

Buy

1

Hold

0

Sell

Technical Score

By Trading Central

6.35 / 6.555Support & Resistance

Short Term

Very Strong Bearish Evidence

Intermediate Term

Bearish Evidence

Long Term

Bearish Evidence

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$